Rethinking platelet function: Thrombocytopenia induced immunodeficiency in critical illness

Medical Hypotheses

Volumn 77, Issue 5, 2011, Pages 798-802

  Ostrowski, Sisse R ^a   Johansson, Pär I ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE RECEPTOR;

ARTICLE; CRITICAL ILLNESS; HEMOSTASIS; HUMAN; IMMUNE DEFICIENCY; IMMUNE DYSREGULATION; IMMUNOCOMPETENCE; IMMUNOCOMPETENT CELL; NONHUMAN; PREDICTIVE VALUE; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA; THROMBOGENESIS;

BLOOD PLATELETS; CRITICAL ILLNESS; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; THROMBOCYTOPENIA;

EID: 80054004330     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.07.040     Document Type: Article

References (74)

1. Nguyen T.C., Carcillo J.A. Bench-to-bedside review: thrombocytopenia-associated multiple organ failure - a newly appreciated syndrome in the critically ill. Crit Care 2006, 10:235.
2. Levi M., Lowenberg E.C. Thrombocytopenia in critically ill patients. Semin Thromb Hemost 2008, 34:417-424.
3. Levi M., Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999, 341:586-592.
4. Dixon B. The role of microvascular thrombosis in sepsis. Anaesth Intensive Care 2004, 32:619-629.
5. von Hundelshausen P., Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res 2007, 100:27-40.
6. Kitchens C.S., Weiss L. Ultrastructural changes of endothelium associated with thrombocytopenia. Blood 1975, 46:567-578.
7. Slichter S.J., Bolgiano D., Jones M.K., et al. Viability and function of 8-day-stored apheresis platelets. Transfusion 2006, 46:1763-1769.
8. Nachman R.L., Rafii S. Platelets, petechiae, and preservation of the vascular wall. N Engl J Med 2008, 359:1261-1270.
9. Goerge T., Ho-Tin-Noe B., Carbo C., et al. Inflammation induces hemorrhage in thrombocytopenia. Blood 2008, 111:4958-4964.
10. Blair P., Flaumenhaft R. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev 2009, 23:177-189.
11. Hanson S.R., Slichter S.J. Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood 1985, 66:1105-1109.
12. Monroe D.M., Roberts H.R., Hoffman M. Platelet procoagulant complex assembly in a tissue factor-initiated system. Br J Haematol 1994, 88:364-371.
13. Monroe D.M., Hoffman M., Roberts H.R. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 2002, 22:1381-1389.
14. Hoffman M., Monroe D.M. A cell-based model of hemostasis. Thromb Haemost 2001, 85:958-965.
15. Monroe D.M., Hoffman M. What does it take to make the perfect clot?. Arterioscler Thromb Vasc Biol 2006, 26:41-48.
16. Esmon C.T. Interactions between the innate immune and blood coagulation systems. Trends Immunol 2004, 25:536-542.
17. Levi M., van der P.T. Inflammation and coagulation. Crit Care Med 2010, 38:S26-S34.
18. Delvaeye M., Conway E.M. Coagulation and innate immune responses: can we view them separately?. Blood 2009.
19. Munnix I.C., Cosemans J.M., Auger J.M., Heemskerk J.W. Platelet response heterogeneity in thrombus formation. Thromb Haemost 2009, 102:1149-1156.
20. Zimmerman G.A., Weyrich A.S. Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function. Arterioscler Thromb Vasc Biol 2008, 28:s17-s24.
21. Rex S., Beaulieu L.M., Perlman D.H., et al. Immune versus thrombotic stimulation of platelets differentially regulates signalling pathways, intracellular protein-protein interactions, and alpha-granule release. Thromb Haemost 2009, 102:97-110.
22. White G.C.I., Rompietti R. Platelet secretion: indiscriminately spewed forth or highly orchestrated?. J Thromb Haemost 2007, 5:2006-2008.
23. Leslie M. Cell biology. Beyond clotting: the powers of platelets. Science 2010, 328:562-564.
24. Smyth S.S., McEver R.P., Weyrich A.S., et al. Platelet functions beyond hemostasis. J Thromb Haemost 2009, 7:1759-1766.
25. Semple J.W., Freedman J. Platelets and innate immunity. Cell Mol Life Sci 2009.
26. Semple J.W., Italiano J.E., Freedman J. Platelets and the immune continuum. Nat Rev Immunol 2011, 11:264-274.
27. Lindemann S., Gawaz M. The active platelet: translation and protein synthesis in an anucleate cell. Semin Thromb Hemost 2007, 33:144-150.
28. Klinger M.H., Jelkmann W. Role of blood platelets in infection and inflammation. J Interferon Cytokine Res 2002, 22:913-922.
29. Weyrich A.S., Zimmerman G.A. Platelets: signaling cells in the immune continuum. Trends Immunol 2004, 25:489-495.
30. Yeaman M.R. The role of platelets in antimicrobial host defense. Clin Infect Dis 1997, 25:951-968.
31. Nomura S., Ozaki Y., Ikeda Y. Function and role of microparticles in various clinical settings. Thromb Res 2008, 123:8-23.
32. Morel O., Toti F., Morel N., Freyssinet J.M. Microparticles in endothelial cell and vascular homeostasis: are they really noxious?. Haematologica 2009, 94:313-317.
33. Boilard E., Nigrovic P.A., Larabee K., et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010, 327:580-583.
34. Freyssinet J.M., Toti F. Formation of procoagulant microparticles and properties. Thromb Res 2010, 125:S46-S48.
35. Sprague D.L., Elzey B.D., Crist S.A., Waldschmidt T.J., Jensen R.J., Ratliff T.L. Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles. Blood 2008, 111:5028-5036.
36. Ratajczak M.Z. Megakaryocyte-derived microvesicles, please stand up!. Blood 2009, 113:981-982.
37. Thery C., Ostrowski M., Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009, 9:581-593.
38. van Gils J.M., Zwaginga J.J., Hordijk P.L. Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases. J Leukoc Biol 2009, 85:195-204.
39. Fitzgerald J.R., Foster T.J., Cox D. The interaction of bacterial pathogens with platelets. Nat Rev Microbiol 2006, 4:445-457.
40. Beaulieu L.M., Freedman J.E. The role of inflammation in regulating platelet production and function: Toll-like receptors in platelets and megakaryocytes. Thromb Res 2009.
41. Cox D., Kerrigan S.W., Watson S.P. Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation. J Thromb Haemost 2011, 9:1097-1107.
42. Yeaman M.R. Platelets in defense against bacterial pathogens. Cell Mol Life Sci 2009.
43. Clemetson K.J. Platelets and pathogens. Cell Mol Life Sci 2009.
44. Aslam R., Speck E.R., Kim M., et al. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood 2006, 107:637-641.
45. Shashkin P.N., Brown G.T., Ghosh A., Marathe G.K., McIntyre T.M. Lipopolysaccharide is a direct agonist for platelet RNA splicing. J Immunol 2008, 181:3495-3502.
46. Clark S.R., Ma A.C., Tavener S.A., et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 2007, 13:463-469.
47. Papayannopoulos V., Zychlinsky A. NETs: a new strategy for using old weapons. Trends Immunol 2009, 30:513-521.
48. Fuchs T.A., Brill A., Duerschmied D., et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci USA 2010, 107:15880-15885.
49. Massberg S., Grahl L., von Bruehl M.L., et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med 2010, 16:887-896.
50. Sun H., Wang X., Degen J.L., Ginsburg D. Reduced thrombin generation increases host susceptibility to group A streptococcal infection. Blood 2009, 113:1358-1364.
51. Nurden A.T., Nurden P., Sanchez M., Andia I., Anitua E. Platelets and wound healing. Front Biosci 2008, 13:3532-3548.
52. Sullam P.M., Frank U., Yeaman M.R., Tauber M.G., Bayer A.S., Chambers H.F. Effect of thrombocytopenia on the early course of streptococcal endocarditis. J Infect Dis 1993, 168:910-914.
53. Fujimi S., MacConmara M.P., Maung A.A., et al. Platelet depletion in mice increases mortality after thermal injury. Blood 2006, 107:4399-4406.
54. McMorran M.J., Marshall V.M., de Graff C., et al. Platelets kill intraerythrocytic malarial parasites and mediate survival to infection. Science 2009, 323:797-800.
55. Rebulla P., Finazzi G., Marangoni F., et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. N Engl J Med 1997, 337:1870-1875.
56. Nevo S., Fuller A.K., Zahurak M.L., Hartley E., Borinsky M.E., Vogelsang G.B. Profound thrombocytopenia and survival of hematopoietic stem cell transplant patients without clinically significant bleeding, using prophylactic platelet transfusion triggers of 10×10(9) or 20×10(9) per L. Transfusion 2007, 47:1700-1709.
57. Sy R.W., Chawantanpipat C., Richmond D.R., Kritharides L. Thrombocytopenia and mortality in infective endocarditis. J Am Coll Cardiol 2008, 51:1824-1825.
58. Brogly N., Devos P., Boussekey N., Georges H., Chiche A., Leroy O. Impact of thrombocytopenia on outcome of patients admitted to ICU for severe community-acquired pneumonia. J Infect 2007, 55:136-140.
59. Chang F.Y., Singh N., Gayowski T., et al. Thrombocytopenia in liver transplant recipients: predictors, impact on fungal infections, and role of endogenous thrombopoietin. Transplantation 2000, 69:70-75.
60. Blasco-Colmenares E., Perl T.M., Guallar E., et al. Aspirin plus clopidogrel and risk of infection after coronary artery bypass surgery. Arch Intern Med 2009, 169:788-796.
61. Skillman J.J., Bushnell L.S., Goldman H., Silen W. Respiratory failure, hypotension, sepsis, and jaundice. A clinical syndrome associated with lethal hemorrhage from acute stress ulceration of the stomach. Am J Surg 1969, 117:523-530.
62. Zhao H., Li S., Yang R. Thrombocytopenia in patients with systemic lupus erythematosus: significant in the clinical implication and prognosis. Platelets 2010.
63. Marks K.M., Clarke R.M., Bussel J.B., Talal A.H., Glesby M.J. Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy. J Acquir Immune Defic Syndr 2009, 52:595-599.
64. Norgaard M., Jensen A.O., Engebjerg M.C., et al. Long-term clinical outcomes of patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study. Blood 2011, 117:3514-3520.
65. Johansson P.I., Stensballe J., Rosenberg I., Hilslov T.L., Jorgensen L., Secher N.H. Proactive administration of platelets and plasma for patients with a ruptured abdominal aortic aneurysm: evaluating a change in transfusion practice. Transfusion 2007, 47:593-598.
66. Bradbury A.W., Bachoo P., Milne A.A., Duncan J.L. Platelet count and the outcome of operation for ruptured abdominal aortic aneurysm. J Vasc Surg 1995, 21:484-491.
67. Cotton B.A., Au B.K., Nunez T.C., Gunter O.L., Robertson A.M., Young P.P. Predefined massive transfusion protocols are associated with a reduction in organ failure and postinjury complications. J Trauma 2009, 66:41-48.
68. Nydam T.L., Kashuk J.L., Moore E.E., et al. Refractory Postinjury Thrombocytopenia Is Associated With Multiple Organ Failure and Adverse Outcomes. J Trauma 2011, 70:401-407.
69. Salim A., Hadjizacharia P., DuBose J., et al. What is the significance of thrombocytosis in patients with trauma?. J Trauma 2009, 66:1349-1354.
70. Erlich J.M., Talmor D.S., Cartin-Ceba R., Gajic O., Kor D.J. Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study. Chest 2011, 139:289-295.
71. Winning J., Neumann J., Kohl M., et al. Antiplatelet drugs and outcome in mixed admissions to an intensive care unit. Crit Care Med 2010, 38:32-37.
72. Shore-Lesserson L. Evidence based coagulation monitors: heparin monitoring, thromboelastography, and platelet function. Semin Cardiothorac Vasc Anesth 2005, 9:41-52.
73. Johansson P.I., Stissing T., Bochsen L., Ostrowski S.R. Thrombelastography and tromboelastometry in assessing coagulopathy in trauma. Scand J Trauma Resusc Emerg Med 2009, 17:45.
74. Link A., Girndt M., Selejan S., Rbah R., Bohm M. Tirofiban preserves platelet loss during continuous renal replacement therapy in a randomised prospective open-blinded pilot study. Crit Care 2008, 12:R111.